1-8 of 8
cromolyn sodium
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Retrospective Case Series Describing the Efficacy of Ketotifen in Systemic Mastocytosis

Calum Anthony Slapnicar, Conrad Scullion Smeenk, Lisa K. Hicks, MD MSc, Jessica Petrucci, MSc, Peter Vadas, MD, Martina Trinkaus, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5474.
https://doi.org/10.1182/blood-2018-99-120112
Published: 2018
Journal Articles

AK002, a Novel Humanized Monoclonal Antibody to Siglec-8, Inhibits Mast Cell Activity and Depletes Eosinophils in Ex Vivo Bone Marrow Tissue from Patients with Systemic Mastocytosis

Bradford A Youngblood, PhD, Emily C Brock, John Leung, Alan T Chang, Christopher Bebbington, PhD, Nenad Tomasevic, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1104.
https://doi.org/10.1182/blood-2018-99-119232
Published: 2018
Journal Articles

Systemic Mastocytosis Patient Experience from Mast Cell Connect, the First Patient-Reported Registry for Mastocytosis

Philina Lee, PhD, Tracy I. George, MD, Hongliang Shi, MS, Erica K. Evans, PhD, Teghpal Singh, PhD, Anthony L Boral, MD PhD, Vanessa Rangel Miller, MS, MBA, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4783.
https://doi.org/10.1182/blood.V128.22.4783.4783
Published: 2016
Journal Articles

Preliminary Safety and Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (SM)

Mark W. Drummond, PhD MD, Daniel J. DeAngelo, MD PhD, Michael W. Deininger, MD PhD, Deepti Radia, MBBS, MRCPI, FRCPath MSc, MD, Albert Thomas Quiery, MD, Elizabeth O Hexner, MD, Hongliang Shi, MS, Terri Alvarez-Diez, PhD, Erica K. Evans, PhD, Mary Ellen Healy, MS, Beni B. Wolf, MD PhD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2016) 128 (22): 477.
https://doi.org/10.1182/blood.V128.22.477.477
Published: 2016
Journal Articles

Doublet Versus Triplet PET: Is END of Therapy PET Needed IF Interim PET Is Negative in Hodgkin'S or Diffuse Large B CELL Lymphoma?

Imran K Tailor, MBBS, MD FRCP, FRCPath, Bilal Btoosh, RN, Shaimaa Hamdy, MD, Shanker Raja, MD, Mohammed O Alharbi, Ibraheem H Motabi, MRCP MD, Nawal Faiez Alshehry, MD SBIM, SBAH, Mohammed S Qureshi, FCPS, Mubarak S. AlGhamdi, MD, Syed Ziauddin A. Zaidi, MBBS, FRCP, FCPS, FRCPath, FACP
Journal: Blood
Blood (2016) 128 (22): 5354.
https://doi.org/10.1182/blood.V128.22.5354.5354
Published: 2016
Journal Articles

Characteristics and Potential Biomarkers for Chronic Pain in Patients with Sickle Cell Disease

Nina Kuei, BS, Niren Patel, MBBS, Hongyan Xu, PhD, Leigh Wells, MS, Latanya Bowman, BS, Pritam Bora, Kavita Natrajan, MBBS, Abdullah Kutlar, MD
Journal: Blood
Blood (2015) 126 (23): 986.
https://doi.org/10.1182/blood.V126.23.986.986
Published: 2015
Journal Articles

Hemin-Induced Mast Cell-Extracellular Traps Impart Resistance to Therapy in a Sickle Microenvironment

Huy Tran, BS, Ritu Jha, M.sc, Julia Nguyen, BS, Sarita Jarrett, High School, Jonathan Rodriguez, Undergraduate, Aditya Mittal, High School, Jianxun Lei, PhD, Kalpna Gupta, PhD
Journal: Blood
Blood (2015) 126 (23): 3385.
https://doi.org/10.1182/blood.V126.23.3385.3385
Published: 2015
Journal Articles

Mast Cell Activation Contributes to Neurogenic Inflammation and Pain in Sickle Cell Disease

Lucile Vincent, PhD, Julia Nguyen, Derek Vang, Oludare B Taiwo, Kathryn Luk, Michael Ansonoff, Marna Ericson, Donald Simone, John E. Pintar, Robert P Hebbel, Kalpna Gupta
Journal: Blood
Blood (2012) 120 (21): 374.
https://doi.org/10.1182/blood.V120.21.374.374
Published: 2012